Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene

Journal of Clinical Pathology

Volumn 49, Issue 4, 1996, Pages 300-305

  Yoshida, K ^a   Sugino, T ^a   Bolodeoku, J ^a   Warren, B F ^b   Goodison, S ^a   Woodman, A ^a   Toge, T ^c   Tahara, E ^b   Tarin, D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Cellular Pathology ^*

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CD44; Colon carcinoma; Exfoliated cancer cells

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SCREENING; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; ULCERATIVE COLITIS;

EID: 0029879533     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.4.300     Document Type: Article

References (27)

1. Heider K-H, Dammrich J, Skroch-Angel P, Muller-Hermelink H-K, Vollmers HP, Herrlich P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993;53:4197-203.
2. Yokozaki H, Ito R, Nakayama H, Kuniyasu H, Taniyama K, Tahara E. Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett 1994;83:229-34.
3. Gou Y-J, Liu G, Wanf X, Jin D, Wu M, Ma J, et al. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994;54:422-6.
4. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992; 340:1053-8.
5. Heider K-H, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993;120:227-33.
6. Mulder J-WR, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;344:1470-2.
7. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993;143:867-74.
8. Kaufmann M, Heider K-H, Sinn H-P, von Minekwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345:615-19.
9. Dali P, Heider K-H, Hekele A, Minckwitz G, Kaufmann M, Ponta H, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994;54:3337-41.
10. Screaton GR, Bell MV, Jackson DG, Corneilis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-4.
11. Stamenkovic I, Aruffo A, Amoiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10:343-8.
12. Matsumura Y, Hanbury D, Smith J, Tarin D. Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 1994;308: 619-24.
13. Sugiyama M, Woodman A, Sugino T, Crowley S, Ho K, Smith J, et al. Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine. J Clin Pathol: Mol Pathol 1995;48: M142-7.
14. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, et al. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995;177:11-20.
15. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren B, et al. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumours. Cancer Res 1995;55:4273-7.
16. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall T, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-9.
17. Haliassos A, Liloglou T, Likourinas M, Doumas C, Ricci N, Spandidos DA. H-ras oncogene mutations in the urine of patients with bladder tumours: description of a non-invasive method for the detection of neoplasia. Int J Oncol 1992;1:731-4.
18. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-5.
19. Hollstein N, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991;253:49-53.
20. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Lew DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
22. Kinzler KW, Nilbert MC, Vogelstein B, Bryan TM, Levy DB, Smith KJ, et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991;251:1366-70.
23. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247:49-56.
24. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a muts homolog, in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266: 2011-15.
26. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-94.
27. Rosenberg WMC, Prince C, Kaklamanis L, Fox SB, Jackson DG, Simmons DL, et al. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet 1995;345:1205-9.